Dr. Reddy’s Labs launches generic version of Allegra-D 12 Hour Allergy & Congestion
HYDERABAD, India – Dr. Reddy’s Labs announced Thursday that it has launched its over-the-counter fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60-mg / 120-mg, a bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion, in the U.S. market.
According to the company, the Allegra-D 12 Hour brand has U.S. sales of approximately $49.8 million for the latest 52 weeks ending Oct. 6, 2014 for total U.S. multi-outlet, citing IRI.
Dr. Reddy’s private label version of Allergra-D 12 Hour will be available in a 20-count blister.
OTC industry moves toward ml-only dosing for children’s liquid formulations
WASHINGTON — The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.
Key changes to the voluntary guidelines include:
- Deleting “spoon” labeling (i.e., teaspoon, tablespoon) on dosing directions and dosing devices;
- Specifying use of “mL” only in dosing directions and on devices; and
- Deleting the provision in dosing directions of a definition of any volumetric unit of measure (i.e., mL = milliliter).
The updated guidelines replace the previous version of this document approved in November 2009 that specifies mL as the preferred unit of measure.
“The makers of OTC medicines fully support using mL as the standard unit of measurement on all liquid orally ingested OTC medicines for children, as we believe this uniformity will make proper dosing easier for parents,” said CHPA resident and CEO Scott Melville. “We know from recent a study released in Pediatrics that parents who used milliliter-only units made fewer dosing errors than those who used teaspoon or tablespoon units. We hope this change combined with the ongoing educational efforts of the CHPA Educational Foundation will contribute to a significant decline in medication errors.”
The changes are supported by the Centers for Disease Control and Prevention PROTECT (Preventing Overdoses and Treatment Errors in Children Taskforce) Initiative, who partners with the CHPA Educational Foundation on the UpandAway.org safe medicine storage campaign.
In addition, the National Council on Prescription Drug Programs has also recommended a move to “mL only” labeling (for prescription liquid medicines), and a recent FDA draft guidance document addressing issues aimed at enhancing safe use of OTC pediatric liquid acetaminophen products also specifies that dosing directions should be provided in mL only.
Matrixx Initiatives launches Zicam Kids
BRIDGEWATER, N.J. — Matrixx Initiatives on Monday launched Zicam Kids, a cold product specifically designed to provide symptom relief for children ages 6 to 11 years. The grape soft chew delivers relief of nasal congestion, runny nose and scratchy throat based on traditional homeopathic practice.
To highlight the new launch, Zicam has introduced a new hero to the pediatric cough-cold aisle, Z-Boy. Z-Boy will be making appearances on Facebook to spread his message of symptom relief through social media.
“Zicam Kids gives mom or dad a great-tasting option for treating a kid’s cold the minute the symptoms start,” said M’lou Arnett, CEO of Matrixx. “Zicam Kids’ great tasting grape chews are safe and effective, but even better, its zinc based, homeopathic formula won’t cause drowsiness or other side effects that worry parents and can side line kids.”
To help drive trial, free samples of Zicam Kids have been placed in various Zicam Rapidmelts packages. “With active moms representing a large percentage of our consumers, we thought there would be no better way to introduce Zicam Kids than to include samples in a Zicam product that moms are already using for their own colds,” said Lori Norian, VP marketing Zicam.
Loading Post Please Wait...